Daily Aspirin May Guard Against Ovarian Cancer
Study of almost 20,000 women found the drug lowered risk by 20 percent
FRIDAY, Feb. 7, 2014 (HealthDay News) -- Taking aspirin every day might lower a woman's risk of developing ovarian cancer by one-fifth, according to research published in the February issue of the Journal of the National Cancer Institute.
Researchers from the U.S. National Cancer Institute analyzed data from 12 studies that involved nearly 8,000 women with ovarian cancer and close to 12,000 women without the disease to determine how the use of aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen (Tylenol) affected the risk of ovarian cancer.
About 18 percent of the women used aspirin regularly, 24 percent used non-aspirin NSAIDs, and 16 percent used acetaminophen. The researchers found that those who used aspirin daily had a 20 percent lower risk of ovarian cancer than those who used aspirin less than once a week. The risk of ovarian cancer was 10 percent lower in women who used non-aspirin NSAIDs at least once a week, compared to those who used them less often. However, this difference was not statistically significant. No link was found between acetaminophen use and ovarian cancer risk.
"Our study suggests that aspirin regimens, proven to protect against heart attack, may reduce the risk of ovarian cancer as well," Britton Trabert, of the National Cancer Institute's division of cancer epidemiology, said in a U.S. National Institutes of Health news release. "However intriguing our results are, they should not influence current clinical practice," she added. "Additional studies are needed to explore the delicate balance of risk and benefit for this potential chemopreventive agent, as well as studies to identify [how] aspirin may reduce ovarian cancer risk."